Sales 2024 * | 48.96B 45.45B 66.94B | Sales 2025 * | 50.79B 47.15B 69.44B | Capitalization | 208B 193B 284B |
---|---|---|---|---|---|
Net income 2024 * | 10.5B 9.75B 14.36B | Net income 2025 * | 12.07B 11.21B 16.5B | EV / Sales 2024 * | 4.51 x |
Net Debt 2024 * | 12.88B 11.95B 17.61B | Net Debt 2025 * | 11.28B 10.47B 15.42B | EV / Sales 2025 * | 4.31 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
17.3
x | Employees | 76,057 |
Yield 2024 * |
3.55% | Yield 2025 * |
3.68% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
-7.93% | 200B | |
+7.68% | 166B | |
-2.71% | 159B |